产品展示更多>>
- SecinH3 853625-60-2

- SecinH3 853625-60-2
SecinH3 853625-60-2
产品描述 描述 SecinH3 is a selective cytohesin inhibitor with IC50 of 2.4 μM, 5.4 μM, 5.4 μM, 5.6 μM, 5.6 μM, and 65 μM for hCyh2, hCyh1, mCyh3, hCyh3, drosophila steppke, and yGea2-S7, respectively.
纯度 >98%储存/保存方法 Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.基本信息 别名 N-(4-(5-(benzo[d][1,3]dioxol-5-yl)-3-methoxy-1H-1,2,4-triazol-1-yl)phenyl)-2-(phenylthio)acetamide外观 白色固体可溶性/溶解性 DMSO : 46.1 mg/mL (100 mM)
Ethanol : 4.6 mg/mL (10 mM), with gentle warming生物活性 靶点 hCyh2,hCyh1,mCyh3,hCyh3,drosophila steppke,,In vitro(体外研究) In HepG2 cells, SecinH3 inhibits insulin signaling and associated gene expression. SecinH3 also markedly inhibits migration of preadipocyte 3T3-L1 cells. In the A549 cells, SecinH3 results in reduced proliferation by indirectly attenuating EGFR activation, and causes a synergistic antiproliferative effect when used in combination with gefitinib.In vivo(体内研究) In mice, SecinH3 increases the expression of gluconeogenic genes, reduces the expression of glycolytic, fatty acid and ketone body metabolism genes in the liver, reduces liver glycogen stores, and increases plasma insulin. In mice bearing H460 xenografts, SecinH3 significantly retards tumor growth through its antiproliferative and pro-apoptotic effect.参考文献 参考文献 研究领域 研究领域 MetabolismCancerCancer MetabolismNeuroscienceEndocrine systemDrug DiscoverySmall Molecule DrugLead Compound DiscoverySecinH3 853625-60-2温馨提示:本产品仅作科研实验使用,不支持临床等研究
